LP Coil System RBYLP0430-BRecalls & reported problems
Penumbra, Inc. · Ruby Coil LP, 4 mm x 30 cm · Class 2 · Implant
All models of LP Coil System (38)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00815948026056), received between Aug 9, 2024 and Apr 22, 2025 — classified as 4 malfunctions.
The most frequently reported specific device problem is “Premature Separation” (3 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Premature Separation3
- Migration1
Patient problems
- No Clinical Signs, Symptoms or Conditions4
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
MalfunctionApr 22, 2025Premature Separation; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE TO TREAT A HEPATIC BLEED USING RUBY COIL LPS AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN SUCCESSFULLY PLACED ONE COIL IN THE TARGET VESSEL. NEXT, THE PHYSICIAN ADVANCED A RUBY COIL LP INTO THE TARGET VESSEL BUT DID NOT LIKE THE WAY THE COIL WAS POSITIONED. THE PHYSICIAN DECIDED TO RETRACT THE RUBY COIL LP. WHILE RETRACTING, THE RUBY COIL LP UNINTENTIONALLY DETACHED WITHIN THE VESSEL. IT WAS REPORTED THAT THE PHYSICIAN USED THE COIL'S PUSHER WIRE TO PUSH THE RUBY COIL LP INTO THE TARGET VESSEL. THE PROCEDURE WAS COMPLETED AT THIS POINT. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21886571 ↗MalfunctionMar 21, 2025Migration; Migration
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE RIGHT INTERNAL MAMMARY VESSEL USING RUBY COIL LPS AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, THE PHYSICIAN ADVANCED A 3MM X 15CM RUBY COIL LP INTO THE TARGET VESSEL. HOWEVER, THE RUBY COIL LP WOULD NOT TAKE ITS INTENDED SHAPE. THEREFORE, THE RUBY COIL LP WAS REMOVED. THE PHYSICIAN ADVANCED A SECOND RUBY COIL LP (2MM X 10 CM) TO THE TARGET VESSEL. HOWEVER, THE SAME ISSUE WAS EXPERIENCED. THEREFORE, THE SECOND RUBY COIL LP WAS REMOVED. THE PHYSICIAN PLACED A NEW RUBY COIL LP (4MM X 30CM) IN THE TARGET VESSEL. WHILE OPENING ANOTHER COIL, THE PHYSICIAN NOTICED UNDER FLUOROSCOPY THAT THE RUBY COIL LP HAD MIGRATED DISTALLY FROM ONE OF THE BRANCHES OF THE BIFURCATION. THE PHYSICIAN INDICATED THE RUBY COIL LP WAS IN A SAFE LOCATION. A GEL FOAM WAS USED TO FILL THE REMAINING SPACE IN THE TARGET SITE COVERING THE RUBY COIL LP. THE PROCEDURE WAS CONSIDERED COMPLETED. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 21663461 ↗MalfunctionDec 13, 2024Premature Separation; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE IN THE GASTRODUODENAL ARTERY (GDA) USING RUBY COIL LPS, AN LP SYSTEM DETACHMENT HANDLE (HANDLE), AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, WHILE ADVANCING THE FIRST RUBY COIL LP INTO THE TARGET LOCATION, THE PHYSICIAN KINKED THE COIL, AND THE RUBY COIL LP HAD UNINTENTIONALLY DETACHED WITHIN THE MICROCATHETER. THEREFORE, THE MICROCATHETER WAS REMOVED CONTAINING THE DETACHED RUBY COIL LP AND THE COIL WAS FLUSHED OUT. THE MICROCATHETER WAS THEN READVANCED BACK INTO THE TARGET LOCATION. NEXT, THE PHYSICIAN WAS UNABLE TO ADVANCE THE SECOND RUBY COIL LP THROUGH THE MICROCATHETER AND THE COIL WAS REMOVED. A THIRD RUBY COIL LP WAS ADVANCED INTO THE VESSEL AND THE PHYSICIAN ATTEMPTED TO DETACH IT USING A HANDLE, BUT THE RUBY COIL LP WOULD NOT DETACH. THEN, WHILE REMOVING THE RUBY COIL LP, THE COIL HAD UNINTENTIONALLY DETACHED. THEREFORE, THE PHYSICIAN USED A SNARE DEVICE TO REMOVE THE DETACHED RUBY COIL LP. IT WAS ALSO REPORTED THAT THE PHYSICIAN DECIDED TO REMOVE AND SWITCH TO A LARGER SIZE MICROCATHETER. THE PROCEDURE WAS COMPLETED USING A POD COIL AND A NEW MICROCATHETER. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO TH
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20926199 ↗MalfunctionAug 9, 2024Premature Separation; Premature Separation
THE PATIENT WAS UNDERGOING A COIL EMBOLIZATION PROCEDURE, IN THE GASTRODUODENAL ARTERY (GDA). USING A RUBY COIL LP AND A NON-PENUMBRA MICROCATHETER. DURING THE PROCEDURE, WHILE ADVANCING THE RUBY COIL LP THROUGH THE MICROCATHETER, THE RUBY COIL LP UNINTENTIONALLY DETACHED WITHIN THE MICROCATHETER. THEREFORE, THE MICROCATHETER CONTAINING THE RUBY COIL LP WAS REMOVED. THE PROCEDURE WAS COMPLETED USING A NON-PENUMBRA COIL AND THE SAME MICROCATHETER. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 19955212 ↗
Other DEVICE, NEUROVASCULAR EMBOLIZATION devices
- POD RBYPODJ60-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION355 reports
- Penumbra System SCH1Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION295 reports
- RUBY Coil RBY4C0860-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION276 reports
- Smart Coil 400SMTHXSFT0208Penumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION165 reports
- Penumbra System RH1-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION154 reports
- Optima Coil System OPTI0208CSS10Balt USA LLC · Device, Neurovascular Embolization3 recalls3 reports
- POD RBYPOD6-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION148 reports
- POD RBYPODJ30-APenumbra, Inc. · DEVICE, NEUROVASCULAR EMBOLIZATION132 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page